162 related articles for article (PubMed ID: 5408050)
1. Duphaston depot, a new long-acting progestogen.
Schellen AM
Bull Soc R Belge Gynecol Obstet; 1969; 39(4):327-31. PubMed ID: 5408050
[No Abstract] [Full Text] [Related]
2. [Indications for dydroprogesterone in gynecology].
Villedieu P; Haour P
Nouv Presse Med; 1972 Sep; 1(34):2255-6. PubMed ID: 4673267
[No Abstract] [Full Text] [Related]
3. [Treatment of the premenstrual syndrome with a retroprogesterone (Duphaston)].
Strecker JR
Fortschr Med; 1980 Jan; 98(4):(145-7). PubMed ID: 7189174
[TBL] [Abstract][Full Text] [Related]
4. [Clinical assays of norgestrel associated with ethinyl estradiol].
Thoyer-Rozat J; Sénèze J; Pierre R; Couderc F
Sem Hop; 1968 Nov; 44(48):2958-62. PubMed ID: 4305737
[No Abstract] [Full Text] [Related]
5. [Further observations on the treatment of premenstrual syndromes associated with dysmenorrhea, using 6-dehydro-retro-progesterone].
Romanini C; Liverani A; Arduini D; Lafuenti G; Manfredi L
Ann Ostet Ginecol Med Perinat; 1979; 100(4):250-65. PubMed ID: 576028
[No Abstract] [Full Text] [Related]
6. [Therapy of endometriosis with dydrogesterone (Duphaston Depot) in delayed-action preparation form].
Obolensky W; Kamber J
Ther Umsch; 1973 Jul; 30(7):558-61. PubMed ID: 4720335
[No Abstract] [Full Text] [Related]
7. [Clinical study of norethisterone acetate in functional metrorrhagia and in pre- and permenstrual painful syndromes].
Anglade JP
Therapie; 1972; 27(5):773-7. PubMed ID: 4675625
[No Abstract] [Full Text] [Related]
8. [Ovulen, its effect on the endometrium, uterine cervix and ovary].
Muller G; Dehalleux JM; Ritter J; Philippe E; Gandar R
Gynecol Obstet (Paris); 1968; 67(5):521-32. PubMed ID: 5730661
[No Abstract] [Full Text] [Related]
9. Effective post-laparoscopic treatment of endometriosis with dydrogesterone.
Trivedi P; Selvaraj K; Mahapatra PD; Srivastava S; Malik S
Gynecol Endocrinol; 2007 Oct; 23 Suppl 1():73-6. PubMed ID: 17943543
[TBL] [Abstract][Full Text] [Related]
10. [Mesoridazine, a new substance for the management of functional disorders in gynecology].
Artner J; Schabel B; Seidl A
Wien Med Wochenschr; 1967 Oct; 117(42):944-8. PubMed ID: 5627408
[No Abstract] [Full Text] [Related]
11. [Bromocriptine in gynecology].
Schindler AE
Dtsch Med Wochenschr; 1979 Mar; 104(10):339-40. PubMed ID: 570910
[No Abstract] [Full Text] [Related]
12. Dydrogesterone (Gynorest and Duphaston).
Med Lett Drugs Ther; 1969 Apr; 11(7):31-2. PubMed ID: 5781648
[No Abstract] [Full Text] [Related]
13. [Therapeutic use of gestagenic preparations and side-effects of their use].
Lysgaard H
Ugeskr Laeger; 1970 Apr; 132(16):742-5. PubMed ID: 5425215
[No Abstract] [Full Text] [Related]
14. [Therapeutic experiences with Praemenstron in the premenstrual syndrome].
Beltermann R
Z Allgemeinmed; 1974 Mar; 50(7):306-1. PubMed ID: 4859173
[No Abstract] [Full Text] [Related]
15. Dydrogesterone in the treatment of the premenstrual syndrome.
Kerr GD; Day JB; Munday MR; Brush MG; Watson M; Taylor RW
Practitioner; 1980 Aug; 224(1346):852-5. PubMed ID: 7001428
[No Abstract] [Full Text] [Related]
16. [A new association of megestrol acetate and ethinyl estradiol in gynecologic therapy. Preliminary results].
Signorelli I; Emanueli A
Minerva Ginecol; 1969 Apr; 21(8):512-22. PubMed ID: 5815438
[No Abstract] [Full Text] [Related]
17. Premenstrual syndrome, dysmenorrhea, and menorrhagia.
Vaughn BM; Ronner W
Curr Opin Obstet Gynecol; 1989 Dec; 1(2):212-5. PubMed ID: 2491123
[No Abstract] [Full Text] [Related]
18. [Female sexual gland hypofunction].
Kobayashi T
Naika; 1970 Jun; 25(6):1135-8. PubMed ID: 5464464
[No Abstract] [Full Text] [Related]
19. Dydrogesterone indications beyond menopausal hormone therapy: an evidence review and woman's journey.
Stute P
Gynecol Endocrinol; 2021 Aug; 37(8):683-688. PubMed ID: 33866898
[TBL] [Abstract][Full Text] [Related]
20. [Current news in the treatment with mammary gland extracts].
Grossi F
Minerva Ginecol; 1975 Aug; 27(8):659-64. PubMed ID: 1221324
[No Abstract] [Full Text] [Related]
[Next] [New Search]
